Loading…

Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG‐ALL‐2015

Background Septicemia is an important cause of treatment‐related mortality and treatment failure in pediatric acute lymphoblastic leukemia (ALL) in developing countries. A multicenter CCCG‐ALL‐2015 study was conducted in China and factors associated with septicemia and mortality were studied. Method...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) MA), 2020-03, Vol.9 (6), p.2113-2121
Main Authors: Zhu, Yiping, Yang, Rong, Cai, Jiaoyang, Yu, Jie, Tang, Yanjing, Chen, Yumei, Wang, Ningling, He, Hailong, Wu, Xuedong, Cheng, Frankie W. T., Sun, Lirong, He, Yingyi, Ju, Xiuli, Tian, Xin, Hu, Qun, Jin, Runming, Pan, Kaili, Fang, Yongjun, Zhai, Xiaowen, Jiang, Hui, Li, Chi‐kong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Septicemia is an important cause of treatment‐related mortality and treatment failure in pediatric acute lymphoblastic leukemia (ALL) in developing countries. A multicenter CCCG‐ALL‐2015 study was conducted in China and factors associated with septicemia and mortality were studied. Methods Patients participated in CCCG‐ALL‐2015 study from January 2015 to December 2017 were included. Patients with documented septicemia were identified from the Data Center and additional data were collected. Results A total of 4080 patients were recruited in the study and 527 patients with septicemia were identified (12.9%, 95% CI 11.9%‐13.9%). The intermediate risk (IR)/high risk (HR) group had significantly higher incidence of septicemia as compared with low risk (LR) group, 17.1% vs 9.1% (OR 2.07, 95% CI 1.71‐2.49, P 
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.2889